Tue.Mar 19, 2024

article thumbnail

A study says intermittent fasting is making people drop dead. Oh, come on

STAT

The news is everywhere in my social news feeds this morning: A popular fad diet is apparently lethal, scientific research says. Specifically, a study found that caloric restriction, also known as intermittent fasting, has a 91% risk of death due to cardiovascular disease. Except scientific research doesn’t say that — and not only should you not be worried about this study, you shouldn’t be wasting brain glucose thinking about it.

364
364
article thumbnail

GSK has the U.S. shingles vaccine market cornered. A jab with fewer side effects could change that.

PharmaVoice

Curevo Vaccine is readying a phase 3 trial for a candidate it believes could have an edge over GSK’s blockbuster Shingrix.

Vaccines 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: The evidence is clear: A liquid-only diet before a colonoscopy is unnecessary

STAT

Since colorectal cancer is on the rise in people younger than age 50, national guidelines have recently pushed the starting age for colorectal cancer screening down to 45. We need to spread the word. Yet we specialists continue to provide outdated and disproven recommendations on colonoscopy bowel preparation that make the process more difficult for the millions of patients who undergo colonoscopy every year: We tell them to adopt a clear liquid diet the day before their procedure.

364
364
article thumbnail

As investors ‘lose trust’ in pharma’s business model, focused M&A strategies can help

PharmaVoice

A rebound in M&A seems to be on the docket, but analysts are warning companies to be intentional about where they go with it.

124
124
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform

STAT

Private equity firms have acquired stakes in nearly one-third of all methadone clinics in recent years, gaining outsize control of the U.S. addiction treatment industry even as the country’s opioid epidemic has developed into a full-fledged public health crisis. A small handful of little-known financial institutions now has an ownership stake in 562 methadone clinics across the country, according to a first-of-its-kind STAT analysis.

364
364
article thumbnail

CCA: Third of Pharmacy First consultations in 20% most deprived communities

The Pharmacist

Almost a third of Pharmacy First consultations carried out by members of the Company Chemists’ Association (CCA) within the first month of the service were provided in the 20% most deprived communities, new data has suggested. Data from the CCA has this week revealed that ‘just over 3,000’ member pharmacies delivered 48,195 Pharmacy First consultations […] The post CCA: Third of Pharmacy First consultations in 20% most deprived communities appeared first on The Pharmacist.

127
127

More Trending

article thumbnail

Improving patient engagement and drug development through AI and enhanced medical affairs roles

pharmaphorum

Learn how AI and enhanced medical affairs roles are transforming the landscape of drug development and patient engagement in the health industry. Explore the benefits and advancements in this exciting field.

article thumbnail

STAT+: UnitedHealth appears to be upping loan offers to providers, after Change cyberattack

STAT

UnitedHealth Group appears to be offering some providers more substantial loans in the wake of the cyberattack on Change Healthcare, according to three doctors who each saw their advances increase up to seven figures. The apparent change comes as hospitals, doctors, and lobbying groups have for weeks complained about low offers from the company, in some cases less than 1% of their typical weekly billing.

Hospitals 327
article thumbnail

Novartis acquisition to address inflammation-driven diseases

European Pharmaceutical Review

Under a new deal, Novartis has agreed to acquire US-based biopharma company IFM Therapeutics, for a total of up to $835 million. As part of this new agreement, Novartis has exercised its option to acquire all outstanding capital stock of IFM Due, a subsidiary company of IFM. Therefore, under the acquisition, Novartis has full rights to IFM Due’s portfolio of small molecule Stimulator of Interferon Genes (STING) antagonists, IFM confirmed.

Immunity 105
article thumbnail

STAT+: In small study, baby aspirin cuts fat buildup in liver disease patients

STAT

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.  The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

PAP 2024: John Hoffman Discusses the Health Equity Spotlight Panel

Pharmaceutical Commerce

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC talks about his 'Health Equity Spotlight' panel and advocacy accomplishments.

105
105
article thumbnail

STAT+: Q&A: Mark Parrino says it’s time to ‘completely re-examine’ methadone treatment for opioid addiction

STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino. For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

321
321
article thumbnail

Wellness Trends Worth Watching Among Younger Patients

Digital Pharmacist

Younger patients are already beginning to dictate the course of modern healthcare, yet they are rarely the focus of pharmacies’ marketing efforts. Their focus on holistic health and lifestyle-based solutions have contributed to an emphasis on mental health and to recent upticks in organic and wellness trends. Pharmacies can take a long-term approach to marketing by closely looking at who their younger patients are and what they need from their local pharmacy.

104
104
article thumbnail

STAT+: Pharmalittle: We’re reading about an AstraZeneca deal, a WHO pandemic pact, and more

STAT

Rise and shine, everyone, another busy day is on the way. Already, the official mascots are racing about the Pharmalot campus in search of breakfast and a steady stream of traffic can be heard nearby. As for us, we are engaged in the usual rituals, starting with brewing cups of stimulation. Our choice today is salted caramel, a veritable whiff of the Jersey shore.

289
289
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

The unmentionables: Challenging inequalities in women’s health

pharmaphorum

As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, but female leaders within life sciences, too.

115
115
article thumbnail

Wegovy and Zepbound get primetime treatment

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at a pioneering new gene therapy, the plight of WuXi AppTec, and a rough month for biotech’s neuroscience renaissance.

271
271
article thumbnail

Managing the challenges and embracing the opportunities of EU-wide HTA

pharmaphorum

Discover the key strategies for managing the challenges and embracing the opportunities of EU-wide Health Technology Assessment (HTA) in partnership with the European Medicines Agency (EMA) and prospective market authorisation holders (pMAHs).

114
114
article thumbnail

US approves first gene therapy for children with rare genetic disease

Express Pharma

Orchard, which was acquired by Japanese pharmaceutical firm Kyowa Kirin for $477.6 million last year, said it will provide details on the pricing and availability of the therapy later in the week The U.S. health regulator on Monday approved UK-based Orchard Therapeutics’ gene therapy to treat children with metachromatic leukodystrophy (MLD), making it the first approved treatment in the United States for the rare, hereditary disease.

Labelling 106
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

NVIDIA doubles down on AI in healthcare with drug discovery deals

Pharmaceutical Technology

In addition to drug discovery deals, NVIDIA also announced partnerships with J&J MedTech and GE Healthcare for genAI in MedTech.

112
112
article thumbnail

AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase

Express Pharma

The deal is AstraZeneca’s second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to shore up its rare disease portfolio AstraZeneca said on Tuesday it will buy clinical stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 billion in cash as the Anglo-Swedish drugmaker bets on next-generation cancer treatments.

article thumbnail

Biologics driving continuous bioprocessing market expansion

European Pharmaceutical Review

According to research by InsightAce Analytic Pvt. Ltd., the global continuous bioprocessing market is expected to value $1,067.8 million by 2031. While the market was valued at $255.9 million in 2023, the report predicted it will witness a CAGR of 19.72 percent between 2024-2031. The research explained that companies are looking to reduce manufacturing costs and increase productivity, which is driving implementation of this type of bioprocessing.

article thumbnail

Do better: The message to the industry from an analysis of clinical evidence submitted to NICE over 20 years

pharmaphorum

Do better: The message to the industry from an analysis of clinical evidence submitted to NICE over 20 years Mike.

124
124
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA unveils comprehensive strategy for regulating AI in medical products

Outsourcing Pharma

With the pharma and healthcare landscape increasingly being shaped by artificial intelligence (AI), the US Food and Drug Administration (FDA) has taken proactive steps to outline a comprehensive strategy for regulating AI in medical products.

89
article thumbnail

Expert Speak | Suresh Garg, Founder & CMD, Zeon Lifesciences

Express Pharma

In this episode of the Express Pharma – Nutrify Today Boardroom series, Suresh Garg, Founder & CMD, Zeon Lifesciences draws upon more than three decades of experience spanning nutrition, dairy products, healthcare, and nutraceuticals, to give insights on how companies like Zeon Lifesciences can achieve success in the global nutraceutical arena.

94
article thumbnail

AZ agrees $2bn deal to buy radiopharma firm Fusion

pharmaphorum

AstraZeneca upgrades its radiopharma alliance with Fusion Pharma, opting to buy the biotech outright in a deal worth around $2 billion

114
114
article thumbnail

Notification issued for multiple GLP1-RA shortages

The Pharmacist

The Department of Health and Social Care (DHSC) has acknowledged multiple ‘high impact’ supply issues with several types of glucagon-like peptide-1 receptor agonists (GLP1-RAs). This week it has issued a ‘high impact’ medicine supply notification for several drugs used to treat type 2 diabetes and weight loss, including: Semaglutide (Ozempic) 0.25mg, 0.5mg and 1mg solution […] The post Notification issued for multiple GLP1-RA shortages appeared first on The Pharmacist.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Burnout at Work: How to Manage Pharmacy Fatigue in 2024

PioneerRx

Pharmacy work is demanding. One minute you’re at the drive thru. The next, you’re answering phone calls or submitting vaccination claims. A day in the pharmacy.

article thumbnail

Bayer cues up filings for rival to Astellas’ menopause drug

pharmaphorum

New phase 3 data sets up filings for Bayer's non-hormonal menopause symptom treatment elinzanetant and a challenge to Astellas’ first-to-market Veozah

108
108
article thumbnail

Biden’s administration initiative aims to advance women’s health conditions

Pharmaceutical Technology

The new initiative aims to spur innovation and mobilisation of sectors to drive women’s health research.

111
111
article thumbnail

DP World expands its global freight forwarding network

Express Pharma

DP World has inaugurated the latest in a string of more than 100 freight forwarding offices across the world. A company statement informed that the offices employ 1,000 staff, adding to DP World’s existing 108,000-strong team and this is expected to grow significantly over the next 12 months, helping move more than 10 per cent of global trade every year.

90
article thumbnail

FDA approves Orchard’s Lenmeldy gene therapy for MLD

Pharmaceutical Technology

The US FDA has granted approval to Orchard Therapeutics' Lenmeldy for specific forms of metachromatic leukodystrophy (MLD).

98